Current position:Home >Product >
2-Chloro-3-(trifluoromethyl)-N-((S)-phenyl((S)-piperidin-2-yl)methyl)benzamide hydrochloride
2-Chloro-3-(trifluoromethyl)-N-((S)-phenyl((S)-piperidin-2-yl)methyl)benzamide hydrochloride(615571-23-8)
- Name: 2-Chloro-3-(trifluoromethyl)-N-((S)-phenyl((S)-piperidin-2-yl)methyl)benzamide hydrochloride
- Synonyms:SSR504734;2-Chloro-3-(trifluoromethyl)-N-((S)-phenyl((S)-piperidin-2-yl)methyl)benzamide hydrochloride
- Molecular Formula:C20H20ClF3N2O.HCl
- Molecular Weight:433
- CAS Registry Number:615571-23-8
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 405887-01-6/Acetic acid, 2-[[2-[(1E)-2-[5-(aminoiminomethyl)-2-hydroxyphenyl]ethenyl]-2,3-dihydro-5-[[1-(1-iminoethyl)-4-piperidinyl]oxy]-1H-indol-1-yl]sulfonyl]-
- 732236-85-0/Acetic acid, 2-[[(2R)-2-[7-(aminoiminomethyl)-2-naphthalenyl]-2,3-dihydro-5-[[1-(1-iminoethyl)-4-piperidinyl]oxy]-1H-indol-1-yl]sulfonyl]-
- 319450-26-5/2-Naphthalenecarboximidamide, 7-[(2R)-1-(ethylsulfonyl)-2,3-dihydro-5-[[1-(1-iminoethyl)-4-piperidinyl]oxy]-1H-indol-2-yl]-, hydrochloride (1:2)
- 753439-35-9/2-Naphthalenecarboximidamide, 7-[(2R)-1-(ethylsulfonyl)-2,3-dihydro-5-[[1-(1-iminoethyl)-4-piperidinyl]oxy]-1H-indol-2-yl]-
- 63435-76-7/Benzenecarboximidamide, 4,4'-[(2-oxo-1,3-cycloheptanediylidene)dimethylidyne]bis-
- 334953-11-6/Glycinamide, 3-[1-(aminoiminomethyl)-4-piperidinyl]-N-[(phenylmethyl)sulfonyl]-D-alanyl-N-[(1S)-4-[(aminoiminomethyl)amino]-1-formylbutyl]- (9CI)
- 186304-04-1/N2-[(Phenylmethyl)sulfonyl]-D-arginyl-N-[(1S)-4-[(aminoiminomethyl)amino]-1-(2-thiazolylcarbonyl)butyl]glycinamide
- 637328-69-9/Tanogitran
- 1004990-28-6/1L-6-HYDROXYMETHYL-CHIRO-INOSITOL 2-(R)-2-O-METHYL-3-O-OCTADECYLCARBONATE
- 310415-30-6/1-[4-[4-[2-(Morpholin-4-yl)-5-nitrobenzoyl]piperazin-1-yl]-3-fluorophenyl]ethanone
- 851337-24-1/1-Phenyl-8-[(1S,2S)-2-phenylcyclohexyl]-1,3,8-triazaspiro[4.5]decan-4-one
- 615571-23-8/2-Chloro-3-(trifluoromethyl)-N-((S)-phenyl((S)-piperidin-2-yl)methyl)benzamide hydrochloride
- 556113-62-3/(2R)-4-[5-Chloro-2-[(4-methoxyphenyl)thio]phenyl]-2-methyl-1-piperazineacetic acid
- 722456-08-8/Org 24598 lithium salt
- 372198-97-5/N-Methyl-N-[(3R)-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl]glycine
- 34042-00-7/DL-BETA-HYDROXYNORVALINE
- 1109-96-2/Silicic acid, ethyl ester
- 692764-89-9/5-(4-Methoxy[1,1'-biphenyl]-3-yl)-1,2,5-thiadiazolidin-3-one 1,1-dioxide
- 612530-44-6/5-Phenyl-1,2,5-thiadiazolidin-3-one 1,1-dioxide
- 941607-78-9/5-[4-(Cyclohexylmethyl)-2-fluoro-6-hydroxyphenyl]-1,2,5-thiadiazolidin-3-one 1,1-dioxide
- 327033-16-9/4-Thiazolidinone, 3-(3-chlorophenyl)-5-[(4-hydroxy-3-methoxy-5-nitrophenyl)methylene]-2-thioxo-
- 446043-04-5/[1,1':4',1''-Terphenyl]-3-methanesulfonic acid, α,α-difluoro-, ammonium salt (9CI)
- 1000611-47-1/Pentanoic acid, 2-[[[(1S)-1-(4-ethyl-2-thiazolyl)-2-[4-(sulfoamino)phenyl]ethyl]amino]carbonyl]-4-methyl-, 1-methyl ester, (2S)-
- 329317-94-4/Methanesulfonamide, N,N'-[1,4-phenylenebis(oxy-4,1-phenylene)]bis[1,1,1-trifluoro- (9CI)
- 864135-09-1/2-Thiophenecarboxylic acid, 4-bromo-3-(carboxymethoxy)-5-[3-[[1-[(phenylmethyl)sulfonyl]-4-piperidinyl]amino]phenyl]-
- 1013907-68-0/L-Tyrosine, N-acetyl-O-[[3'-[[[4-(1-ethylpropyl)phenyl](1-methylethyl)amino]methyl][1,1'-biphenyl]-4-yl]methyl]-
- 745079-13-4/3-Isoxazolecarboxylic acid, 4-amino-5-[3-[(1E)-3-[3-hydroxy-2-(methoxycarbonyl)phenoxy]-1-propen-1-yl]phenyl]-
- 623563-74-6/Benzoic acid, 2-[4-[[(2S)-3-[4-[1-carboxy-2-(cyclopropylamino)-2-oxoethoxy]phenyl]-2-[[(1,1-dimethylethoxy)carbonyl]amino]-1-oxopropyl]amino]butoxy]-6-hydroxy-, 1-methyl ester
- 845609-54-3/4-[4-[2-(Cyclopropylmethoxy)-5-methylsulfonylbenzoyl]piperazin-1-yl]-3-fluorobenzonitrile
- 186369-21-1/N2-[(Phenylmethyl)sulfonyl]-D-arginyl-N-[(1S)-4-[(aminoiminomethyl)amino]-1-formylbutyl]glycinamide